Dayno Jeffrey M.'s Form 4 filing
Harmony Biosciences Holdings, Inc. (HRMY) · filed Jan 23, 2025
- Accession no.
- 0001415889-25-001931
- Filed
- Jan 23, 2025
- Trade date
- Jan 21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $774.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dayno Jeffrey M.CIK 0001615993 | Director, Officer (PRESIDENT, CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | Common Stock | MOption exerciseAcquired | +19,293 | $8.22 | +$158,588.46 | 19,293 | Direct | |
| Jan 21, 2025 | Common Stock | SSaleDisposed | −19,293 | $40.13 | −$774,228.09 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | Common Stock | MOption exerciseDisposed | −3,470 | $0.00 | $0 | 20,000 | Direct | |
| Jan 21, 2025 | Common Stock | MOption exerciseDisposed | −6,086 | $0.00 | $0 | 0 | Direct | |
| Jan 21, 2025 | Common Stock | MOption exerciseDisposed | −9,737 | $0.00 | $0 | 2,435 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.